Elysium Health’s Clinically-Validated Product Basis

Co-founded by Dr. Leonard Guarente, the director of the Paul F. Glenn Center for Biology of Aging Research, Elysium Health is a consumer health company. The research of Elysium Health is guided by the company’s scientific advisory board. The company is focused on translating advances in science and technology into clinically-validated health products that work.

Currently, Elysium Health makes the supplement Basis. Basis is made up of two ingredients, nicotinamide riboside and pterostilbene, which is proven  to increase and sustain levels of NAD+ in our cells. This essential coenzyme is essential to many of our cellular functions like DNA maintenance, circadian rhythms, and energy creation. Our levels of NAD+ decline naturally as we age, and those functions break down.

To make sure that Basis works as advertised, Elysium Health put the supplement through a clinical trial in 2016. During the trial, 120 subjects were divided into three even groups. Group one took two capsules of Basis, which is the recommended daily dose of the supplement. Group two took four capsules of the supplement, which is double the recommended daily dose of Basis. Group three took a placebo. Those who took the recommended dose of Basis during the trial had their NAD+ levels rise by an average of 40 percent and remain there for the duration of the trial.

Visit Elysium Health’s website to purchase Basis. The company sells Basis in a variety of monthly subscriptions, as well as in individual jars. Each jar contains 60 capsules (the recommended daily intake is two capsules). A standard monthly subscription costs $50 each month. Longer subscriptions cost more upfront but offer discounts on the monthly rate.

More information on Elysium Health, the company’s team of scientists, and the science behind Basis can be found on Elysium’s website.


Leave a Reply

Your email address will not be published. Required fields are marked *